PAM
NMTC icon

Premier Asset Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Premier Asset Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,333
Closed -$197K – 157
2021
Q3 		$197K Hold
8,333
– – 0.03% 152
2021
Q2 		$332K Buy
+8,333
New +$352K 0.05% 170

Other funds holding NMTC

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
DWM
Drive Wealth Management Lehi, Utah $561M AUM 33.14% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $514M AUM 29.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Premier Asset Management's NMTC Position: Q4 2021 in Review

Premier Asset Management sold out of NeuroOne Medical Technologies (NMTC) in Q4 2021, closing a stake of 8,333 shares — an estimated $197K sold.

Premier Asset Management first reported a position in NMTC in Q2 2021 and held it in 2 quarters. The position peaked at $332K in Q2 2021. 16 funds tracked by Wall St. Rank hold NMTC as of Q4 2021.

  • Premier Asset Management reported no remaining NeuroOne Medical Technologies position as of Q4 2021 after selling out during the quarter.
  • Premier Asset Management sold 8,333 NeuroOne Medical Technologies shares in Q4 2021, an estimated $197K.
  • Premier Asset Management first reported a position in NeuroOne Medical Technologies in Q2 2021 and held it in 2 quarters.
  • Premier Asset Management's NeuroOne Medical Technologies position peaked at $332K in Q2 2021.
  • 16 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2021.

Based on Premier Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.